Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Using psychological treatments can help manage skin conditions along with regular medical care.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Using finasteride with TIP extends time off period for prostate cancer patients.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Thymosin β4 helps improve skin healing and reduce scarring.

Suppressing certain hormones might help prevent prostate cancer.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.